Please confirm you are human (Sign Up for free to never see this)
← Back to Search
The Relationship Between The Structure And Biological Actions Of Green Tea Catechins.
C. Braicu, M. Ladomery, V. Chedea, A. Irimie, I. Berindan-Neagoe
Published 2013 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Catechins and their gallate esters are a class of polyphenolic compounds. The catechin subclass known as flavan-3-ols have recently attracted much attention with regards to their beneficial effect on human health. Their biological actions are dependent on the structure of the compounds and vary according to cell type. They are best known as powerful antioxidants; however depending on the doses they also exhibit prooxidant effects. The anti- or prooxidant effects of green tea catechins have been implicated in the modulation of several cellular functions often associated with strong chemoprotective properties. This review summarises the benefit catechins to human health, the main molecular pathways modulated by catechins. The relationship between the structure and activity of the catechins needs to be studied further. In the future, the structure of catechins could be modified so as to synthesise novel compounds with more specific beneficial properties and higher bioavailability.
This paper references
Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells
M. Cavet (2011)
Chemoprevention of lung cancer by tea.
Julie Clark (2006)
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
B. Sutherland (2006)
Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice.
M. Anderson (2008)
Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study
C. Simons (2009)
Green tea and the prevention of breast cancer: a case-control study in Southeast China.
M. Zhang (2007)
Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
H. Youn (2006)
Epigallocatechin‐3‐gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex
Y. C. Lim (2011)
Role of catechin quinones in the induction of EpRE-mediated gene expression.
Małgorzata Muzolf-Panek (2008)
Interaction between the carboxyl-terminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate.
M. Sazuka (1998)
The relative antioxidant activities of plant-derived polyphenolic flavonoids.
C. Rice-Evans (1995)
Free radicals and antioxidants in normal physiological functions and human disease.
M. Valko (2007)
Antioxidant/prooxidant activity of a polyphenolic grape seed extract
V. Chedea (2010)
Anti-obesity effects of green tea: from bedside to bench.
S. Wolfram (2006)
Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.
S. Lamy (2002)
Why drinking green tea could prevent cancer
J. Jankun (1997)
A Green Tea Extract High in Catechins Reduces Body Fat and Cardiovascular Risks in Humans
T. Nagao (2007)
Mechanistic issues concerning cancer prevention by tea catechins.
C. Yang (2011)
Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.
H. Tachibana (2009)
Substances that can change alternative splice-site selection.
C. Sumanasekera (2008)
Radical scavenging activity of tea catechins and their related compounds.
F. Nanjo (1999)
Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.
G. Lu (2006)
Cancer prevention by tea and tea polyphenols.
C. Yang (2008)
Polyphenols from Cocoa and Vascular Health—A Critical Review
G. Rimbach (2009)
(-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation.
D. Shin (2009)
Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)
M. Ravindranath (2009)
The chemistry of tea flavonoids.
D. A. Balentine (1997)
Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity.
P. Chantre (2002)
Importance of a pyrogallol-type structure in catechin compounds for apoptosis-inducing activity.
K. Saeki (2000)
Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins.
S. Mandel (2008)
Antioxidants in food and food antioxidants.
F. Shahidi (2000)
O. Weinreb (2009)
Mechanistic issues concerning cancer prevention
C. S. Yang (2011)
Beneficial effects of green tea: A literature review
Sabu M Chacko (2010)
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines
Gerd Stammler (1997)
Green tea and its polyphenolic catechins: Medicinal uses
N. T. Zaveri (2006)
Anti-obesity effects of green tea
S. 777 Wolfram (2006)
The connection between splicing and cancer
A. Srebrow (2006)
Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal caco-2 cells.
Janjira Intra (2007)
Flavonoids: Promising anticancer agents
W. Ren (2003)
Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.
M. Inoue (2008)
Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans
H. Tsuneki (2004)
Apoptosis in cancer: Key molecular signaling pathways and therapy targets
C. Burz (2009)
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
S. Ahmed (2008)
Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Y. Tang (2007)
Induction of full-length survival motor neuron by polyphenol botanical compounds
Mary S. Sakla (2007)
Plant polyphenols as dietary antioxidants in human health and disease
K. Pandey (2009)
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.
M. Shammas (2006)
Dual function of (--)-epigallocatechin gallate (EGCG) in healthy human lymphocytes.
Masaki Kanadzu (2006)
Growth Inhibitory and Antimetastatic Effect of Green Tea Polyphenols on Metastasis-Specific Mouse Mammary Carcinoma 4T1 Cells In vitro and In vivo Systems
M. S. Baliga (2005)
Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
R. Yamauchi (2009)
J. 665 Vervoort (2008)
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
S. Mandel (2004)
EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
S. Anderson (2003)
Anti‐proliferative and proapoptotic effects of (−)‐epigallocatechin‐3‐gallate on human melanoma: Possible implications for the chemoprevention of melanoma
M. Nihal (2005)
Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
J. Carlson (2007)
Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail
A. Bode (2009)
Natural products and colon cancer: current status and future prospects
Subapriya Rajamanickam (2008)
Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
D. Nagle (2006)
Catechin as an antioxidant in liver mitochondrial toxicity: Inhibition of tamoxifen‐Induced protein oxidation and lipid peroxidation
H. Tabassum (2007)
Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCG
Masahito Shimizu (2008)
Green tea catechins and cardiovascular health: an update.
P. V. A. Babu (2008)
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
N. Khan (2006)
Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
N. Zaveri (2006)
Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies
J. Liu (2008)
Cancer prevention by tea and tea constituents
J. M. Landau (2005)
Siebold's New Researches in Parthenogenesis
E. R. Lankestek (1872)
cDNA gene expression profile
O. 774 Weinreb (2003)
Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts.
J. Suzuki (2006)
Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.
T. Kondo (2002)
C. Young (2014)
Inhibition of Breast
C. Agarwal (2006)
Iron and α-synuclein in the substantia nigra of MPTP-treated mice
S. Mandel (2007)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
C. Yang (2009)
A Novel Look into Estrogen Receptor–Negative Breast Cancer Prevention with the Natural, Multifunctional Signal Transduction Inhibitor Deguelin
J. M. Rodenberg (2009)
Role of nutrition in preventing cancer.
R. Béliveau (2007)
Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.
L. Chen (2007)
Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits.
N. Seeram (2003)
Ascorbic acid offsets the inhibitory effect of bioactive dietary polyphenolic compounds on transepithelial iron transport in Caco-2 intestinal cells.
E. Kim (2011)
The combination of green tea and tamoxifen is effective against breast cancer.
M. Sartippour (2006)
Molecular targets of dietary agents for prevention and therapy of cancer.
B. Aggarwal (2006)
(-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells.
S. Cho (2007)
Role of chemopreventive agents in cancer therapy.
T. Dorai (2004)
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines
M. Ravindranath (2006)
Green tea catechins inhibit VEGF‐induced angiogenesis in vitro through suppression of VE‐cadherin phosphorylation and inactivation of Akt molecule
Feng-Yao Tang (2003)
Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism.
C. Ko (2009)
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.
N. Ahmad (1997)
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells
O. Weinreb (2003)
Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.
Jungil Hong (2002)
Cancer prevention by tea
C. S. Yang (2009)
Identification of epigallocatechin782 3gallate in green tea polyphenols as a potent inducer of p 53dependent 783 apoptosis in the human lung cancer cell line A 549
R. Yamauchi (2009)
Anti-proliferative and differentiation-inducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophilic leukemia EoL-1 cell line.
H. Lung (2002)
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
W. Ahn (2003)
The comparison of effect of catechins and green tea extract on oxidative modification of LDL in vitro.
J. Ostrowska (2006)
Antiobesity effects of green tea catechins: a mechanistic review.
T. M. Rains (2011)
Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity.
L. Zheng (2008)
Modulatory Effects of Polyphenols on Apoptosis Induction: Relevance for Cancer Prevention
M. D'Archivio (2008)
Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
O. Weinreb (2009)
Biological Activities of Polyphenols from Grapes
En-Qin Xia (2010)
This paper is referenced by
In vitro gastrointestinal digest of catechin-modified β-conglycinin oxidized by lipoxygenase-catalyzed linoleic acid peroxidation.
Lianzhu Lin (2019)
Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
Andreia Granja (2017)
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
Simona Izzo (2020)
Preparative HSCCC isolation of phloroglucinolysis products from grape seed polymeric proanthocyanidins as new powerful antioxidants.
S. Zhang (2015)
Geographic and intraspecific variability of mesquitol amounts in Prosopis juliflora trees from Kenya
Sarah cherono Chepkwony (2020)
Oxidative DNA damage protective activity and antioxidant potential of Ashtvarga species growing in the Indian Himalayan Region
L. Giri (2017)
Cornea Therapeutic Efficacy of Nanocomplex of Poly ( Ethylene Glycol ) and Catechin for Dry Eye Disease in a Mouse Model
Hyesook Lee (2017)
Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells
A. Irimie (2015)
Benefits of Wine Polyphenols on Human Health: A Review
Roxana Banc (2014)
Tea (Camellia Sinensis (L.)): a Putative Anticancer Agent in Bladder Carcinoma?
Vanessa R Conde (2014)
Improvement of nutritional and physicochemical proprieties of milk chocolates enriched with kale (Brassica olereacea var. acephala) and grape (Vitis vinífera)
J. Carvalho (2018)
Binding of tea catechins to rice bran protein isolate: Interaction and protective effect during in vitro digestion.
M. Shi (2017)
Analytical determination of flavonoids aimed to analysis of natural samples and active packaging applications.
M. M. Castro-López (2014)
Green tea mechanism of action in fighting different types of cancer
A. Ibrahim (2016)
Difference in formation mechanism of inclusion complex between configuration isomers of gallate-type catechin and β-cyclodextrin
H. Ikeda (2018)
Interactions between β-cyclodextrin and tea catechins, and potential anti-osteoclastogenesis activity of the (−)-epigallocatechin-3-gallate–β-cyclodextrin complex
H. Xu (2019)
Antioxidant Activities of Selected Berries and Their Free, Esterified, and Insoluble-Bound Phenolic Acid Contents
Ji-Sang Kim (2018)
Synergistic, antagonistic and additive interactions of green tea polyphenols
M. Colón (2015)
Enhancement of Phthalocyanine Mediated Photodynamic Therapy by Catechin on Lung Cancer Cells
Giftson J Senapathy (2020)
Polyphenols, antioxidants, and antimutagenic effects of Copaifera langsdorffii fruit.
Â. G. Batista (2016)
Tea polyphenols association to caseinate-stabilized oil–water interfaces
Somayeh Sabouri (2015)
Phytochemistry and bioactivity of Acacia sensu stricto (Fabaceae: Mimosoideae)
Diana Jæger (2018)
Fabrication of Chitosan-Polyethylene Oxide Electrospun Nanofibrous Mats Containing Green Tea Extract
A. Barzegari (2018)
Flavonoids as Anticancer Agents
D. Kopustinskiene (2020)
Efeito do consumo diário de chá branco no córtex cerebral de ratos pré-diabéticos
Ana Raquel Mendes da Paula Nunes (2014)
Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
Jin-Jing Jia (2017)
New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies.
Mei Zhang (2020)
Nanodelivery of Natural Antioxidants: An Anti-aging Perspective
A. Vaiserman (2019)
Beneficial effects of (-)-epigallocatechin-3-O-gallate on diabetic peripheral neuropathy in the rat model.
O. Abo-Salem (2020)
Functional targeting of the TGF-βR1 kinase domain and downstream signaling: A role for the galloyl moiety of green tea-derived catechins in ES-2 ovarian clear cell carcinoma.
Audrey-Ann Sicard (2020)
Immunohistochemical Study of the Effect of Green Tea Extract on Methotrexate- Induced Oral Mucositis in Albino Rats
Al-Refai A Sultan (2014)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
A. Cano (2019)See more